Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2024-08-02
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Versus Late Drain Removal After Pancreatectomy: A Randomized Prospective Trial
NCT02230436
Post-operative Drainage After Pancreaticoduodenectomy
NCT05270564
Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT
NCT01907750
Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy
NCT03055676
Long Time Follow up After HJ Following Iatrogenic Bile Duct Injuries
NCT01447030
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Patient admitted for donor hepatectomy will be recruited and further randomised into the Drain and No-Drain arms. Patients in the no drain arm will undergo routine steps in donor hepatectomy. After graft removal, hemostasis and biliostasis will be confirmed, following which abdomen will be closed in layers. For patients in the drain arm, same steps will be followed. At the end of the operation , additionally, 28 Fr abdominal drain will be inserted with tip near cut surface of remnant. Intraoperative and post-operative parameters will be compared between the groups. Comprehensive Complication index will be calculated on day of discharge using online universal CCI calculator application.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drain
Patients in the drain arm will undergo routine steps in donor hepatectomy. After graft removal, hemostasis and biliostasis will be confirmed, following which at the end of the operation ,a 28 Fr abdominal drain will be inserted with tip near cut surface of remnant
No interventions assigned to this group
No Drain
Patients in the no drain arm will undergo routine steps in donor hepatectomy. After graft removal, hemostasis and biliostasis will be confirmed, following which abdomen will be closed in layers. No intraabdominal drain will be placed.
No Drain i.e. Omission of abdominal drain placement
Omission of abdominal drain placement in intervention arm. The No-drain arm will be compared to drain arm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Drain i.e. Omission of abdominal drain placement
Omission of abdominal drain placement in intervention arm. The No-drain arm will be compared to drain arm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
Inverted L/ J shaped incision. Laparoscopic donor hepatectomy Robotic donor hepatectomy.
\-
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marengo Asia Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bharat Nair
Principle Investigator. Consultant , Department of HPB surgery and liver Transplant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Punit Singla, MS,DNB
Role: STUDY_DIRECTOR
Marengo Asia Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marengo Asia Hospitals
Faridabad, Haryana, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAHF/AP/LTP-1/EC/2024/04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.